Description
xVolapride® contains Levosulpiride 50 mg, a selective dopamine D2 receptor antagonist with prokinetic and gastroprotective properties. It is commonly prescribed for the management of gastrointestinal motility disorders associated with delayed gastric emptying and functional dyspepsia. By enhancing gastrointestinal motility and improving gastric emptying, Volapride® helps relieve symptoms such as nausea, vomiting, bloating, early satiety, abdominal discomfort, and gastroesophageal reflux.
Levosulpiride also exerts antiemetic effects by blocking dopamine receptors in the chemoreceptor trigger zone, making it effective in controlling nausea and vomiting associated with various gastrointestinal conditions.
Ingredients
x| Levosulpiride USP | 50 mg |
Benefits
x* Improves gastric motility and accelerates gastric emptying.
* Provides effective relief from functional dyspepsia.
* Helps reduce nausea and vomiting.
* Relieves bloating, fullness, abdominal discomfort, and indigestion.
* Supports the management of gastroesophageal reflux symptoms associated with delayed gastric emptying
- Choosing a selection results in a full page refresh.